Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Zyban (Bupropion Hydrochloride) Sustained-Release Tablets
Company:  GlaxoWellcome Inc.
Application No.:  20-711/S12
Approval Date: 2/7/2001


Date created: May 30, 2002

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.